iSpecimen Inc. Deferred Tax Assets, Tax Credit Carryforwards, Research
iSpecimen Inc. (ISPC) had Deferred Tax Assets, Tax Credit Carryforwards, Research of $2.06 million as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Notes
us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch · last filed 2024-03-13
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $2.06M.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $1.09M.
- 2021-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $850.00K.
- 2020-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $700.00K.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards, Research |
|---|---|
| 2023-12-31 | $2.06M 10-K · filed 2024-03-13 |
| 2022-12-31 | $1.09M 10-K · filed 2024-03-13 |
| 2021-12-31 | $850.00K 10-K/A · filed 2023-03-30 |
| 2020-12-31 | $700.00K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |